Celiac Disease & Gluten-Related Disorders Protocol
Celiac Disease & Gluten-Related Disorders Protocol framework focused on consistent execution, practical monitoring, and safer progression.
An adjunctive protocol for individuals with celiac disease or non-celiac gluten sensitivity, targeting the intestinal barrier dysfunction, autoimmune mucosal damage, and nutritional malabsorption that persist despite gluten-free diet adherence.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
Celiac Disease & Gluten-Related Disorders Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
Ongoing on strict gluten-free diet; reassess mucosal healing (tTG antibodies) at 6-month intervals
Target Audience
Adults with confirmed celiac disease with incomplete mucosal healing despite gluten-free diet; non-celiac gluten sensitivity patients
| Compound | Dose | Frequency |
|---|---|---|
| Larazotide Acetate Zonulin antagonism; directly addresses the tight junction pathology driving celiac intestinal permeability | 0.5 mg | Three times daily with meals |
| BPC-157 Villous repair and mucosal architecture restoration in celiac-damaged intestine | 250 mcg | Twice daily (oral) |
| KPV NF-κB inhibition in intestinal epithelium and lamina propria; reduces Th1 mucosal inflammation | 500 mcg | Daily |
| VIP Reduces Th1-mediated anti-gliadin mucosal inflammation; promotes intestinal Treg activity | 25 nmol | Daily |
| Thymosin Alpha-1 Modulates anti-gliadin T-cell responses; promotes tolerance restoration in celiac mucosal immunity | 1.6 mg | 3x/week |
| LL-37 Restores antimicrobial defense layer damaged in celiac intestinal barrier breach | 500 mcg | 3x/week |
Free Peptide Guide
Celiac Disease & Gluten-Related Disorders Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned Larazotide Acetate timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should Celiac Disease & Gluten-Related Disorders Protocol run before reassessment?
A common window is Ongoing on strict gluten-free diet; reassess mucosal healing (tTG antibodies) at 6-month intervals, with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with Larazotide Acetate + BPC-157 execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Celiac disease involves HLA-DQ2/DQ8-restricted T-cell reactivity to gliadin epitopes, villous atrophy, and intestinal barrier disruption driven by zonulin-mediated tight junction disassembly. Even on strict gluten-free diet, mucosal healing is incomplete in up to 60% of adults. Larazotide Acetate directly antagonizes zonulin, the key driver of tight junction opening in celiac disease, and is the most clinically validated peptide in celiac RCTs. BPC-157 promotes intestinal villous repair and restores mucosal architecture damaged by the autoimmune attack. KPV suppresses NF-κB in intestinal epithelium and lamina propria immune cells. VIP reduces the Th1-mediated mucosal inflammation. Thymosin Alpha-1 modulates the anti-gliadin T-cell response. LL-37 restores the antimicrobial defense layer in the compromised celiac intestinal barrier.
Clinical Research
No clinical references were provided for this stack yet.
More Immune Support Stacks
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
An adjunctive protocol for individuals with ankylosing spondylitis and axial spondyloarthropathy, targeting the IL-17/IL-23-driven enthesitis, progressive syndesmophyte formation, and the TNF-driven inflammatory cascade that cause irreversible spinal fusion.
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
Anti-inflammatory and joint-protective peptide protocol for ankylosing spondylitis targeting spinal inflammation, syndesmophyte prevention, and preservation of spinal mobility.
Crohn's Disease & IBD Management Protocol
Peptide-based protocol targeting intestinal inflammation, barrier repair, and mucosal immune regulation for Crohn's disease and ulcerative colitis management.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
Celiac Disease & Gluten-Related Disorders Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.